» Articles » PMID: 32046526

Exercise Intolerance and Fatigue in Chronic Heart Failure: is There a Role for Group III/IV Afferent Feedback?

Overview
Date 2020 Feb 13
PMID 32046526
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Exercise intolerance and early fatiguability are hallmark symptoms of chronic heart failure. While the malfunction of the heart is certainly the leading cause of chronic heart failure, the patho-physiological mechanisms of exercise intolerance in these patients are more complex, multifactorial and only partially understood. Some evidence points towards a potential role of an exaggerated afferent feedback from group III/IV muscle afferents in the genesis of these symptoms. Overactivity of feedback from these muscle afferents may cause exercise intolerance with a double action: by inducing cardiovascular dysregulation, by reducing motor output and by facilitating the development of central and peripheral fatigue during exercise. Importantly, physical inactivity appears to affect the progression of the syndrome negatively, while physical training can partially counteract this condition. In the present review, the role played by group III/IV afferent feedback in cardiovascular regulation during exercise and exercise-induced muscle fatigue of healthy people and their potential role in inducing exercise intolerance in chronic heart failure patients will be summarised.

Citing Articles

Correlation of Sit-to-Stand Test and 6-Minute Walk Test to Illustrate Cardiorespiratory Fitness in Systolic Heart Failure Patients.

Triangto I, Dhamayanti A, Putra M, Witjaksono D, Rahmad , Zuhriyah L Ann Rehabil Med. 2025; 49(1):23-29.

PMID: 40033954 PMC: 11895058. DOI: 10.5535/arm.240057.


Effect of a new resistance training method on the metaboreflex in cardiac rehabilitation patients: a randomized controlled trial.

Gillet A, Grolaux T, Forton K, Ibrahim M, Lamotte M, Roussoulieres A Eur J Appl Physiol. 2024; 124(12):3693-3705.

PMID: 39102020 DOI: 10.1007/s00421-024-05570-8.


Consequences of group III/IV afferent feedback and respiratory muscle work on exercise tolerance in heart failure with reduced ejection fraction.

Smith J, Senefeld J, Larson K, Joyner M Exp Physiol. 2023; 108(11):1351-1365.

PMID: 37735814 PMC: 10900130. DOI: 10.1113/EP090755.


The Effect of Skeletal Muscle Oxygenation on Hemodynamics, Cerebral Oxygenation and Activation, and Exercise Performance during Incremental Exercise to Exhaustion in Male Cyclists.

Cherouveim E, Miliotis P, Koskolou M, Dipla K, Vrabas I, Geladas N Biology (Basel). 2023; 12(7).

PMID: 37508410 PMC: 10376807. DOI: 10.3390/biology12070981.


The relationship between stress and sleep quality: The mediating effect of fatigue and dizziness among patients with cardiovascular disease.

Park H, Oh J Medicine (Baltimore). 2023; 102(20):e33837.

PMID: 37335686 PMC: 10194731. DOI: 10.1097/MD.0000000000033837.


References
1.
Amann M, Blain G, Proctor L, Sebranek J, Pegelow D, Dempsey J . Implications of group III and IV muscle afferents for high-intensity endurance exercise performance in humans. J Physiol. 2011; 589(Pt 21):5299-309. PMC: 3225681. DOI: 10.1113/jphysiol.2011.213769. View

2.
Amann M, Sidhu S, Weavil J, Mangum T, Venturelli M . Autonomic responses to exercise: group III/IV muscle afferents and fatigue. Auton Neurosci. 2014; 188:19-23. PMC: 4336599. DOI: 10.1016/j.autneu.2014.10.018. View

3.
OLeary D, Senador D, Augustyniak R . Muscle metaboreflex-induced central blood volume mobilization in heart failure. Am J Physiol Heart Circ Physiol. 2019; 316(5):H1047-H1052. PMC: 6580386. DOI: 10.1152/ajpheart.00805.2018. View

4.
Nobrega A, OLeary D, Silva B, Marongiu E, Piepoli M, Crisafulli A . Neural regulation of cardiovascular response to exercise: role of central command and peripheral afferents. Biomed Res Int. 2014; 2014:478965. PMC: 4000959. DOI: 10.1155/2014/478965. View

5.
Amann M, Proctor L, Sebranek J, Pegelow D, Dempsey J . Opioid-mediated muscle afferents inhibit central motor drive and limit peripheral muscle fatigue development in humans. J Physiol. 2008; 587(1):271-83. PMC: 2670040. DOI: 10.1113/jphysiol.2008.163303. View